RESUMO
Non-exudative age-related macular degeneration (NE-AMD), the main cause of blindness in people above 50 years old, lacks effective treatments at the moment. We have developed a new NE-AMD model through unilateral superior cervical ganglionectomy (SCGx), which elicits the disease main features in C57Bl/6J mice. The involvement of oxidative stress in the damage induced by NE-AMD to the retinal pigment epithelium (RPE) and outer retina has been strongly supported by evidence. We analysed the effect of enriched environment (EE) and visual stimulation (VS) in the RPE/outer retina damage within experimental NE-AMD. Exposure to EE starting 48 h post-SCGx, which had no effect on the choriocapillaris ubiquitous thickness increase, protected visual functions, prevented the thickness increase of the Bruch's membrane, and the loss of the melanin of the RPE, number of melanosomes, and retinoid isomerohydrolase (RPE65) immunoreactivity, as well as the ultrastructural damage of the RPE and photoreceptors, exclusively circumscribed to the central temporal (but not nasal) region, induced by experimental NE-AMD. EE also prevented the increase in outer retina/RPE oxidative stress markers and decrease in mitochondrial mass at 6 weeks post-SCGx. Moreover, EE increased RPE and retinal brain-derived neurotrophic factor (BDNF) levels, particularly in Müller cells. When EE exposure was delayed (dEE), starting at 4 weeks post-SCGx, it restored visual functions, reversed the RPE melanin content and RPE65-immunoreactivity decrease. Exposing animals to VS protected visual functions and prevented the decrease in RPE melanin content and RPE65 immunoreactivity. These findings suggest that EE housing and VS could become an NE-AMD promising therapeutic strategy.
Assuntos
Degeneração Macular/fisiopatologia , Células Fotorreceptoras/metabolismo , Epitélio Pigmentado da Retina/metabolismo , Fatores Etários , Animais , Modelos Animais de Doenças , CamundongosRESUMO
Nonexudative age-related macular degeneration (NE-AMD) represents the leading cause of blindness in the elderly. Currently, there are no available treatments for NE-AMD. We have developed a NE-AMD model induced by superior cervical ganglionectomy (SCGx) in C57BL/6J mice, which reproduces the disease hallmarks. Several lines of evidence strongly support the involvement of oxidative stress in NE-AMD-induced retinal pigment epithelium (RPE) and outer retina damage. Melatonin is a proven and safe antioxidant. Our aim was analysing the effect of melatonin in the RPE/outer retina damage within experimental NE-AMD. The treatment with melatonin starting 48 h after SCGx, which had no effect on the ubiquitous choriocapillaris widening, protected visual functions and avoided Bruch´s membrane thickening, RPE melanin content, melanosome number loss, retinoid isomerohydrolase (RPE65)-immunoreactivity decrease, and RPE and hotoreceptor ultrastructural damage induced within experimental NE-AMD exclusively located at the central temporal (but not nasal) region. Melatonin also prevented the increase in outer retina/RPE oxidative stress markers and a decrease in mitochondrial mass at 6 weeks post-SCGx. Moreover, when the treatment with melatonin started at 4 weeks post-SCGx, it restored visual functions and reversed the decrease in RPE melanin content and RPE65-immunoreactivity. These findings suggest that melatonin could become a promising safe therapeutic strategy for NE-AMD.
Assuntos
Degeneração Macular/patologia , Melatonina/farmacologia , Retina/efeitos dos fármacos , Animais , Antioxidantes/farmacologia , Camundongos , Camundongos Endogâmicos C57BL , Estresse Oxidativo/efeitos dos fármacosRESUMO
Neuroinflammatory diseases are characterized by blood-brain barrier disruption (BBB) and leukocyte infiltration. We investigated the involvement of monocyte recruitment in visual pathway damage provoked by primary optic neuritis (ON) induced by a microinjection of bacterial lipopolysaccharide (LPS) into the optic nerve from male Wistar rats. Increased Evans blue extravasation and cellularity were observed at 6 h post-LPS injection. In WT-GFPþ/WT chimeric rat optic nerves, the presence of GFP(+) neutrophils and GFP(+) monocytes, and in wild-type rat optic nerves, an increase in CD11b+CD45low and CD11b+CD45high cell number, were observed at 24 h post-LPS. Gamma-irradiation did not affect the increase in BBB permeability, but significantly lessened the decrease in pupil light reflex (PLR), and retinal ganglion cell (RGC) number induced by LPS. At 6 h post-LPS, an increase in chemokine (C-C motif) ligand 2 (CCL2) immunoreactivity co-localized with neutrophils (but not microglia/macrophages or astrocytes) was observed, while at 24 h post-injection, an increase in Iba-1-immunoreactivity and its co-localization with CCL2 became evident. The co-injection of LPS with bindarit (a CCL2 synthesis inhibitor) lessened the effect of LPS on PLR, and RGC loss. The treatment with etoposide or gadolinium chloride that significantly decreased peripheral monocyte (but not neutrophil or lymphocyte) percentage decreased the effect of LPS on PLR, and RGC number. Moreover, a negative correlation between PRL and monocyte (but not lymphocyte or neutrophil) percentage was observed at 7 days post-LPS. Taken together, these results support that monocytes are key players in the initial events that take place during primary ON.
Assuntos
Monócitos/patologia , Nervo Óptico/patologia , Neurite Óptica/patologia , Animais , Barreira Hematoencefálica/efeitos dos fármacos , Barreira Hematoencefálica/patologia , Quimiocina CCL2/metabolismo , Indazóis/administração & dosagem , Indazóis/farmacologia , Lipopolissacarídeos/administração & dosagem , Lipopolissacarídeos/farmacologia , Masculino , Monócitos/efeitos dos fármacos , Nervo Óptico/efeitos dos fármacos , Nervo Óptico/efeitos da radiação , Permeabilidade , Propionatos/administração & dosagem , Propionatos/farmacologia , Ratos Wistar , Proteínas Recombinantes/farmacologia , Ativador de Plasminogênio Tecidual/farmacologiaRESUMO
Optic neuritis (ON) is an inflammatory, demyelinating, neurodegenerative, and presently untreatable condition of the optic nerve which might induce blindness. We analyzed the effect of environmental enrichment (EE) on visual pathway damage provoked by experimental ON induced by a microinjection of bacterial lipopolysaccharide (LPS) into the optic nerve. For this purpose, LPS was microinjected into the optic nerve from male Wistar rats. After injection, one group of animals was submitted to EE, and another group remained in standard environment (SE) for 21 days. EE prevented the decrease in pupil light reflex (PLR), visual evoked potentials, retinal anterograde transport, phosphorylated neurofilament immunoreactivity, myelination (luxol fast blue staining), and axon (toluidine blue staining) and retinal ganglion cell (Brn3a-immunoreactivity) number. EE also prevented microglial/macrophage reactivity (Iba-1- and ED1-immunoreactivity), and astrocytosis (glial fibrillary acidic protein-immunostaining) induced by experimental ON. LPS-injected optic nerves displayed oxidative damage and increased inducible nitric oxide synthase, cyclooxygenase-2, and interleukin-1ß and TNFα mRNA levels which were prevented by EE. EE increased optic nerve brain-derived neurotrophic factor levels. When EE started at 4 (but not 7) days post-injection of LPS, a preservation of the PLR was observed at 21 days post-LPS, which was blocked by the daily administration of ANA-12 from day 4 to day 7 post-LPS. Moreover, EE from day 4 to day 7 post-LPS significantly preserved the PLR at 21 days post-injection. Taken together, our data suggest that EE preserved visual functions and reduced neuroinflammation of the optic nerve. This article is part of the Special Issue entitled "Neurobiology of Environmental Enrichment".
Assuntos
Meio Ambiente , Neurite Óptica/terapia , Animais , Axônios/metabolismo , Axônios/patologia , Modelos Animais de Doenças , Potenciais Evocados Visuais , Abrigo para Animais , Masculino , Neuroglia/metabolismo , Neuroglia/patologia , Nervo Óptico/patologia , Nervo Óptico/fisiopatologia , Neurite Óptica/patologia , Neurite Óptica/fisiopatologia , Distribuição Aleatória , Ratos Wistar , Reflexo Pupilar , Células Ganglionares da Retina/metabolismo , Células Ganglionares da Retina/patologia , Vias Visuais/patologia , Vias Visuais/fisiopatologiaRESUMO
Optic neuritis (ON) is an inflammatory, demyelinating, and neurodegenerative condition of the optic nerve, which might induce permanent vision loss. Currently, there are no effective therapies for this disorder. We have developed an experimental model of primary ON in rats through a single microinjection of 4.5 µg of bacterial lipopolysaccharide (LPS) into the optic nerve. Since melatonin acts as a pleiotropic therapeutic agent in various neurodegenerative diseases, we analyzed the effect of melatonin on LPS-induced ON. For this purpose, LPS or vehicle were injected into the optic nerve from adult male Wistar rats. One group of animals received a subcutaneous pellet of 20 mg melatonin at 24 hr before vehicle or LPS injection, and another group was submitted to a sham procedure. Melatonin completely prevented the decrease in visual evoked potentials (VEPs), and pupil light reflex (PLR), and preserved anterograde transport of cholera toxin ß-subunit from the retina to the superior colliculus. Moreover, melatonin prevented microglial reactivity (ED1-immunoreactivity, P < 0.01), astrocytosis (glial fibrillary acid protein-immunostaining, P < 0.05), demyelination (luxol fast blue staining, P < 0.01), and axon (toluidine blue staining, P < 0.01) and retinal ganglion cell (Brn3a-immunoreactivity, P < 0.01) loss, induced by LPS. Melatonin completely prevented the increase in nitric oxide synthase 2, cyclooxygenase-2 levels (Western blot) and TNFα levels, and partly prevented lipid peroxidation induced by experimental ON. When the pellet of melatonin was implanted at 4 days postinjection of LPS, it completely reversed the decrease in VEPs and PLR. These data suggest that melatonin could be a promising candidate for ON treatment.
Assuntos
Melatonina/farmacocinética , Fármacos Neuroprotetores/farmacologia , Neurite Óptica/prevenção & controle , Animais , Ciclo-Oxigenase 2/metabolismo , Modelos Animais de Doenças , Peroxidação de Lipídeos/efeitos dos fármacos , Lipopolissacarídeos/toxicidade , Masculino , Óxido Nítrico Sintase Tipo II/metabolismo , Neurite Óptica/induzido quimicamente , Neurite Óptica/metabolismo , Neurite Óptica/patologia , Ratos , Ratos Wistar , Fator de Necrose Tumoral alfa/metabolismoRESUMO
Glaucoma is a leading cause of blindness. Although ocular hypertension is the most important risk factor, several concomitant factors such as elevation of glutamate and decrease in gamma-aminobutyric acid (GABA) levels, disorganized NO metabolism, and oxidative damage could significantly contribute to the neurodegeneration. The aim of this report was to analyze the effect of melatonin on retinal glutamate clearance, GABA concentrations, NO synthesis, and retinal redox status, as well as on functional and histological alterations provoked by chronic ocular hypertension induced by intracameral injections of hyaluronic acid (HA) in the rat eye. In normal retinas, melatonin increased glutamate uptake, glutamine synthase activity, GABA turnover rate, glutamic acid decarboxylase activity, superoxide dismutase activity, and reduced glutathione (GSH) levels, whereas it decreased NOS activity, L-arginine uptake, and lipid peroxidation. To assess the effect of melatonin on glaucomatous neuropathy, weekly injections of HA were performed in the eye anterior chamber. A pellet of melatonin was implanted subcutaneously 24 hr before the first injection or after six weekly injections of HA. Melatonin, which did not affect intraocular pressure (IOP), prevented and reversed the effect of ocular hypertension on retinal function (assessed by electroretinography) and diminished the vulnerability of retinal ganglion cells to the deleterious effects of ocular hypertension. These results indicate that melatonin could be a promissory resource in the management of glaucoma.
Assuntos
Glaucoma/tratamento farmacológico , Melatonina/farmacologia , Fármacos Neuroprotetores/farmacologia , Retina/efeitos dos fármacos , Animais , Arginina/metabolismo , Glaucoma/metabolismo , Glutamato Descarboxilase/metabolismo , Ácido Glutâmico/metabolismo , Histocitoquímica , Pressão Intraocular/efeitos dos fármacos , Cinética , Masculino , Óxido Nítrico Sintase/metabolismo , Estresse Oxidativo , Ratos , Ratos Wistar , Retina/metabolismo , Células Ganglionares da Retina , Ácido gama-Aminobutírico/metabolismoRESUMO
Circadian variations of prostaglandin E2 and F2alpha release were examined in the golden hamster retina. Both parameters showed significant diurnal variations with maximal values at midnight. When hamsters were placed under constant darkness for 48 h, the differences in prostaglandin release between subjective mid-day and subjective midnight persisted. Western blot analysis showed that cyclooxygenase (COX)-1 levels were significantly higher at midnight than at mid-day, and at subjective midnight than at subjective mid-day, whereas no changes in COX-2 levels were observed among these time points. Immunohistochemical studies indicated the presence of COX-1 and COX-2 in the inner (but not outer) retina. Circadian variations of retinal prostaglandin release were also assessed in suprachiasmatic nuclei (SCN)-lesioned animals. Significant differences in retinal prostaglandin release between subjective mid-day and subjective midnight were observed in SCN-lesioned animals. These results indicate that hamster retinal prostaglandin release is regulated by a retinal circadian clock independent from the SCN. Thus, the present results suggest that the prostaglandin/COX-1 system could be a retinal clock output or part of the retinal clock mechanism.
Assuntos
Ritmo Circadiano/fisiologia , Dinoprosta/metabolismo , Dinoprostona/metabolismo , Mesocricetus/anatomia & histologia , Retina/metabolismo , Animais , Cricetinae , Ciclo-Oxigenase 1/metabolismo , Ciclo-Oxigenase 2/metabolismo , Escuridão , Técnicas In Vitro , Masculino , Atividade Motora/fisiologia , Fotoperíodo , Núcleo Supraquiasmático/lesões , Núcleo Supraquiasmático/fisiologia , Fatores de Tempo , Trítio/metabolismoRESUMO
OBJECTIVE: To investigate the use of a single intravitreal injection of bacterial lipopolysaccharide (LPS) to experimentally induce uveitis in cats. ANIMALS: 7 young male European shorthair cats that were considered physically and ophthalmologically healthy. PROCEDURES: In each cat, LPS was injected intravitreally into 1 eye; the contralateral eye was injected with the preparation vehicle. During a period of 45 days, both eyes were evaluated by means of clinical evaluation; assessment of the integrity of the blood-aqueous humor barrier (determined via measurement of protein concentration and cell content in samples of aqueous humor); functional analysis (via electroretinography); and following euthanasia, histologic examination of the retinas. RESULTS: In LPS-treated eyes, several clinical signs were observed until day 45 after injection. Compared with vehicle-treated eyes, intraocular pressure was significantly lower and protein concentration and the number of infiltrating cells were significantly higher in LPS-treated eyes. Mean amplitudes of scotopic electroretinographic a- and b-waves were significantly reduced in eyes injected with LPS, compared with findings in eyes injected with vehicle. At 45 days after injection, LPS-induced alterations in photoreceptors and the middle portion of the retina were detected histologically. CONCLUSION AND CLINICAL RELEVANCE: Results indicated that a single intravitreal injection of LPS in eyes of cats induced clinical, biochemical, functional, and histologic changes that were consistent with the main features of naturally occurring uveitis. This technique may be a useful tool in the investigation of new treatment strategies for uveitis in cats.
Assuntos
Doenças do Gato/induzido quimicamente , Doenças do Gato/patologia , Lipopolissacarídeos/toxicidade , Uveíte/veterinária , Análise de Variância , Animais , Gatos , Eletrorretinografia/veterinária , Lipopolissacarídeos/administração & dosagem , Uveíte/induzido quimicamente , Uveíte/patologiaRESUMO
PURPOSE: The purpose of this study was to investigate whether bacterial lipopolysaccharide (LPS) induces ischemic preconditioning in the rat retina, and, if so, whether nitric oxide (NO) is involved in this process. METHODS: Rats were intravitreously injected with different doses of LPS (0.1, 1, or 5 microg) in one eye and vehicle in the contralateral eye 24 hours before retinal ischemia induced by increasing intraocular pressure to 120 mm Hg for 40 or 60 minutes. Subsequently, 7 or 14 days after ischemia, the rats were subjected to electroretinography and histologic analysis. One group of animals received intraperitoneal injections of NOS inhibitors, N-nitro-L-arginine methyl ester (L-NAME) aminoguanidine or N-(3-(aminomethyl)benzyl)acetamidine (W1400) before the injection of LPS or vehicle. Retinal nitric oxide synthase (NOS) activity was assessed through the conversion of (3)H-L-arginine to (3)H-L-citrulline. RESULTS: One microgram (but not 0.1 or 5 microg) LPS afforded significant morphologic and functional protection in eyes exposed to ischemia-reperfusion injury. The beneficial effect of LPS was reversed by treatment with L-NAME, aminoguanidine, or W1400. LPS (1 and 5 microg, but not 0.1 microg) significantly increased retinal NOS activity. CONCLUSIONS: These results indicate that LPS provides retinal protection against ischemia-reperfusion injury in a dose-dependent manner, probably through an inducible NOS-dependent mechanism.
Assuntos
Precondicionamento Isquêmico , Lipopolissacarídeos/farmacologia , Traumatismo por Reperfusão/prevenção & controle , Doenças Retinianas/prevenção & controle , Vasos Retinianos/fisiopatologia , Salmonella typhimurium , Animais , Relação Dose-Resposta a Droga , Eletrorretinografia , Inibidores Enzimáticos/farmacologia , Guanidinas , Injeções , Masculino , Óxido Nítrico/metabolismo , Óxido Nítrico Sintase Tipo II/metabolismo , Ratos , Ratos Wistar , Traumatismo por Reperfusão/metabolismo , Traumatismo por Reperfusão/fisiopatologia , Doenças Retinianas/metabolismo , Doenças Retinianas/fisiopatologia , Corpo VítreoRESUMO
Pregnancy maintenance is a very complex phenomenon, and the mechanisms that allow the survival of the fetus within the maternal uterus are still poorly understood. Our objectives were to analyze heme oxygenase (HO) activity and expression in the pregnant rat and to study its association with steroid hormones and prostaglandins. Uterine tissues were obtained from non-pregnant and from time-mated rats at days 5, 13, 18-22 of pregnancy and postpartum. HO activity was significantly higher at days 5 and 20 while HO-1 protein levels measured by Western blot, were significantly elevated from days 19 to 22. In ovariectomized rats, estrogen and progesterone in estrogenized animals increased HO activity and expression. Cyclooxygenase inhibitors augmented HO activity and HO-1 expression. Pre-incubation with prostaglandin F2alpha (PGF2alpha) diminished the enzymatic activity in ovariectomized rat uterus. Tin protoporphyrin IX, an HO inhibitor, significantly decreased uterine cGMP accumulation. Bilirubin decreased uterine thiobarbituric acid substances levels (an index of lipid peroxidation). These results demonstrate a uterine gestational pattern of HO activity and expression in the rat. In addition, these results suggest that uterine HO activity could regulate uterine quiescence in pregnancy via cGMP and it may contribute to the defense against oxidative stress.
Assuntos
Monóxido de Carbono/metabolismo , Hormônios Esteroides Gonadais/fisiologia , Heme Oxigenase (Desciclizante)/metabolismo , Prostaglandinas/fisiologia , Útero/enzimologia , Animais , GMP Cíclico/metabolismo , Feminino , Heme Oxigenase-1/metabolismo , Estresse Oxidativo/fisiologia , Gravidez , Ratos , Ratos WistarRESUMO
The photic regulation of heme oxygenase (HO) activity was examined in the golden hamster retina. This enzymatic activity was significantly higher at midday than at midnight. When the hamsters were placed under constant darkness for 48 h and killed at subjective day or at subjective night, the differences in HO activity disappeared. Western blot analysis showed no differences in HO levels among these time points. Dopamine significantly increased this activity in retinas excised at noon or at midnight, with a higher sensitivity at night. The effect of dopamine was reversed by SCH 23390 but not by spiperone and clozapine and it was not reproduced by quinpirole. In vitro, the increase in HO activity found in retinas incubated under light for 1 h was significantly reduced by SCH 23390. Two cAMP analogs increased HO activity and their effect, as well as the effect of dopamine was blocked by H-89, a protein kinase A (PKA) inhibitor. Tin protoporphyrin IX, an HO inhibitor, significantly decreased cGMP accumulation with maximal effects during the day. Low concentrations of bilirubin decreased retinal thiobarbituric acid substances levels (an index of lipid peroxidation) in basal conditions and after exposing retinal cells to H2O2. These results suggest that hamster retinal HO activity is regulated by the photic stimulus, probably through a dopamine/cAMP/PKA dependent pathway.
Assuntos
Dopamina/metabolismo , Heme Oxigenase (Desciclizante)/metabolismo , Fotoperíodo , Retina/metabolismo , Animais , Benzazepinas/farmacologia , Bilirrubina/farmacologia , Bucladesina/farmacologia , Ritmo Circadiano/fisiologia , Clozapina/farmacologia , Cricetinae , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , GMP Cíclico/metabolismo , Dopamina/farmacologia , Agonistas de Dopamina/farmacologia , Antagonistas de Dopamina/farmacologia , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Heme Oxigenase (Desciclizante)/antagonistas & inibidores , Técnicas In Vitro , Masculino , Mesocricetus , Quimpirol/farmacologia , Retina/efeitos dos fármacos , Retina/enzimologia , Espiperona/farmacologia , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismoRESUMO
The aim of the present study was to analyze the early events elicited by tumor necrosis factor alpha (TNF-alpha) on monocyte-derived dendritic cells (moDC) adhesion to fibronectin (FN) and the involvement of cAMP in the signal transduction mechanism. The intracellular concentration of cAMP and moDC adhesion to FN decreased after TNF-alpha treatment. An inverted dose-dependency for TNF-alpha effect was observed for adhesion and cAMP levels. The presence of a phosphodiesterase (PDE) inhibitor (IBMX) and cAMP analogs (8Br-cAMP, Db-cAMP) reversed the observed TNF-alpha effects. The role of cAMP was analyzed further by examining the cAMP levels in nonadhered and adhered, TNF-alpha-treated moDC. Nonadhered moDC showed lower cAMP levels compared with adhered moDC. Furthermore, nonadhered moDC showed higher IL-12 content and allostimulatory ability compared with adhered moDC. The higher allostimulatory capacity was abolished in the presence of cAMP analogs and a PDE inhibitor. These results suggest that cAMP levels correlate with TNF-alpha-induced changes of moDC adhesion and allostimulatory capacity.
Assuntos
Adesão Celular , AMP Cíclico/metabolismo , Células Dendríticas/imunologia , Fibronectinas/metabolismo , Células Cultivadas , Células Dendríticas/efeitos dos fármacos , Humanos , Interleucina-12/biossíntese , Ativação Linfocitária , Monócitos/imunologia , Células-Tronco/imunologia , Linfócitos T/imunologia , Fator de Necrose Tumoral alfa/farmacologiaRESUMO
One of the limiting steps in the regulation of nitric oxide (NO) synthesis is the availability of its precursor, L-arginine, which depends on the presence of a specific uptake system. A characterization of the L-arginine uptake mechanism in the golden hamster retina was performed. This mechanism was stereospecific, saturable, and monophasic, with an apparent of 56.1 +/- 2.0 microM and a maximum velocity of 36.0 +/- 2.8 pmol/mg prot/min. The basic amino acids L-lysine and L-ornithine but not D-arginine or the nitric oxide synthase inhibitors, N(omega)-nitro-L-arginine methyl ester and N(omega)-nitro-L-arginine impaired L-arginine influx. Preincubation with L-lysine for 1 h prior to the transport assay significantly stimulated L-arginine uptake. Saturation studies of L-arginine uptake performed at 12.00 and 24.00 h indicated a higher value of Vmax at midnight than at midday. When the hamsters were placed under constant darkness or constant light for 48 h and killed at equivalent time points, representing subjective day and subjective night, the differences in L-arginine influx disappeared. Semiquantitative RT-PCR analysis showed that the levels of mRNAs for both CAT-1 and CAT-2B were significantly higher at midnight than at midday. L-Arginine significantly increased cGMP accumulation in a time-dependent manner, with maximal effects during the night. Based on these results, it might be presumed that hamster retinal L-arginine uptake is regulated by the photic stimulus.
Assuntos
Arginina/farmacocinética , Transportador 1 de Aminoácidos Catiônicos/metabolismo , Retina/metabolismo , Animais , Transportador 1 de Aminoácidos Catiônicos/genética , Transportador 2 de Aminoácidos Catiônicos/genética , Transportador 2 de Aminoácidos Catiônicos/metabolismo , Cricetinae , GMP Cíclico/metabolismo , Expressão Gênica/fisiologia , Masculino , Mesocricetus , Estimulação Luminosa , Fotoperíodo , RNA Mensageiro/análise , Transdução de Sinais/fisiologia , TrítioRESUMO
Mediante el empleo de 3H-flunitrazepam (FNZP) como ligando radiactivo se detectó en sobrenadantes de 3 000 g de glándula pineal de rata una única población de sitios de unión para benzodiazepinas (BZP) de constante de disociación= 97-102 nM y número de sitios de unión= 6.5-9 pmoles/mg proteína. La afinidad de diversas BZP por este sitio de unión (Ki, nM) fue: Ro 5-4864 (8), FNZP (99), clonazepam (7 900), Ro 15-1788 (10 000). Dos semanas después de una gangliectomía cervical superior bilateral (Gx) se observó una disminución significativa de 18-28 % en los sitios de unión pineales para BZP, sin modificaciones en la afinidad. In vitro, 0.1-10 uM de Ro 5-4864 o diazepam (pero no clonazepam) disminuyeron significativamente la liberación de norepinefrina pineal ante un estímulo despolarizante de K+ (80 nM). En concentración 10 uM las tres BZP aumentaron los niveles de melatonina pineal in vitro. En glándulas pineales de ratas sometidas dos semanas antes a Gx sólo el Ro 5-4864 fue efectivo en aumentar la síntesis de melatonina in vitro. Estos resultados sugieren que las BZP disminuyen la liberación de neurotrasmisor de los nervios pineales por acción sobre un sitio de unión de tipo periférico, siendo este efecto unos dos órdenes de magnitud mayor que la estimulación postsináptica de la síntesis de melatonina
Assuntos
Ratos , Animais , Masculino , Benzodiazepinas/farmacologia , Técnicas In Vitro , Melatonina/metabolismo , Norepinefrina/metabolismo , Glândula Pineal/metabolismo , Sítios de LigaçãoRESUMO
Mediante el empleo de 3H-flunitrazepam (FNZP) como ligando radiactivo se detectó en sobrenadantes de 3 000 g de glándula pineal de rata una única población de sitios de unión para benzodiazepinas (BZP) de constante de disociación= 97-102 nM y número de sitios de unión= 6.5-9 pmoles/mg proteína. La afinidad de diversas BZP por este sitio de unión (Ki, nM) fue: Ro 5-4864 (8), FNZP (99), clonazepam (7 900), Ro 15-1788 (10 000). Dos semanas después de una gangliectomía cervical superior bilateral (Gx) se observó una disminución significativa de 18-28 % en los sitios de unión pineales para BZP, sin modificaciones en la afinidad. In vitro, 0.1-10 uM de Ro 5-4864 o diazepam (pero no clonazepam) disminuyeron significativamente la liberación de norepinefrina pineal ante un estímulo despolarizante de K+ (80 nM). En concentración 10 uM las tres BZP aumentaron los niveles de melatonina pineal in vitro. En glándulas pineales de ratas sometidas dos semanas antes a Gx sólo el Ro 5-4864 fue efectivo en aumentar la síntesis de melatonina in vitro. Estos resultados sugieren que las BZP disminuyen la liberación de neurotrasmisor de los nervios pineales por acción sobre un sitio de unión de tipo periférico, siendo este efecto unos dos órdenes de magnitud mayor que la estimulación postsináptica de la síntesis de melatonina (AU)